-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Kairos Pharma, LTD. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from 2023 to 2024.
- Kairos Pharma, LTD. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.05M, a 236% decline year-over-year.
- Kairos Pharma, LTD. annual Net Income (Loss) Attributable to Parent for 2024 was -$2.6M, a 43.7% decline from 2023.
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)